Adiponectin is a major regulator of glucose and lipid homeostasis via its insulin‐sensitizing properties, and the reduction in this adipokine is associated with the development of metabolic syndrome and type 2 diabetes (Fang and Sweeney 2006). The gene discussed is ADIPOQ; the disease is metabolic syndrome.